Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Arrhythmias (Amiodarone hydrochloride - Arrhythmias)

Records returned : 22 (on 29 May 2025 at 11:12:39). Return to search results for ' Arrhythmias '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Amber
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Intravenous infusion
  • Intravenous injection (IV)
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Un
Indication :
Status :
Green
Formulations :
  • Elixir
  • Tablets
Restrictions / Comments:

Important
ONE 62.5mcg tablet is equivalent to 50mcg (1ml) of elixir
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Modified release capsules
  • Oral solution
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Capsules
Restrictions / Comments:

Important
Specialist initiation and at least one month supply before transfer to primary care
 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important
Specialist initiation and at least one month supply before transfer to primary care
 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Specialist initiation and at least one month supply before transfer to primary care
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Unlicensed. For use or advice by cardiology consultants only.
 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Specialist initiation and at least one month supply before transfer to primary care
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
  • Intravenous infusion
Restrictions / Comments:

Important
Restricted to cardiology / Theatres / ITU / Resus
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Infusion
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Capsules
Restrictions / Comments:

Important

Cardiology specialists only.

Namuscla brand is non-preferred for this indication

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Unlicensed
 
Links :
SPC